We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.
Consensus vs. actual, and revenue trend
Consensus PT $32.25 · 4 analysts
Stored first · Google News · Yahoo Finance (English)
INVX: Raising target price to $27.00
Innovex International (INVX) Joins Russell Indexes, Is The Upside Already Priced In? - simplywall.st
Innovex International (INVX) Joins Russell Indexes, Is The Upside Already Priced In? simplywall.st
ETFs Investing in Innovex International, Inc. Stocks - TradingView
ETFs Investing in Innovex International, Inc. Stocks TradingView
Innovex International (NYSE:INVX) Russell Index Inclusion Draws Attention - Kalkine Media
Innovex International (NYSE:INVX) Russell Index Inclusion Draws Attention Kalkine Media
Is Broad Russell Index Inclusion Altering The Investment Case For Innovex International (INVX)? - simplywall.st
Is Broad Russell Index Inclusion Altering The Investment Case For Innovex International (INVX)? simplywall.st
INVX - Innovex International Inc Latest SEC Filings - Finviz
INVX - Innovex International Inc Latest SEC Filings Finviz
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 05. 04. | After market close (AMC) | $0.3 | — | — | $241.09M | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $0.21 | — | — | $240.42M | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $3.08 | — | — | $410.12M | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $0.8 | — | — | $258.3M | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 18. | Piper Sandler | — | Maintain | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2026. 05. 09. | Barclays | — | Maintain | Equal-Weight → Equal-Weight | — | Barclays: Equal-Weight |
| 2026. 05. 08. | Citigroup | — | Initiate coverage | — → Buy | — | Citigroup: Buy |
| 2026. 03. 04. | Barclays | — | Maintain | Equal-Weight → Equal-Weight | — | Barclays: Equal-Weight |
| 2025. 12. 18. | Piper Sandler | — | Maintain | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2025. 11. 14. | Barclays | — | Upgrade | Underweight → Equal-Weight | — | Barclays: Underweight → Equal-Weight |
As of FY2026Q1 · Source: SEC/DART + price data
No holdings data to show.